Provided by Tiger Trade Technology Pte. Ltd.

Amgen

407.44
-5.6400-1.37%
Post-market: 407.440.00000.00%19:59 EDT
Volume:2.38M
Turnover:965.64M
Market Cap:219.40B
PE:25.31
High:411.84
Open:409.97
Low:400.06
Close:413.08
52wk High:447.03
52wk Low:288.00
Shares:538.48M
Float Shares:536.99M
Volume Ratio:0.89
T/O Rate:0.44%
Dividend:9.80
Dividend Rate:2.41%
EPS(TTM):16.10
EPS(LYR):14.23
ROE:91.47%
ROA:8.67%
PB:18.77
PE(LYR):28.63

Loading ...

Wells Fargo Adjusts Price Target on Amgen to $435 From $400, Keeps Equalweight Rating

MT Newswires Live
·
Sep 04

Political and General News Events from September 3

Reuters
·
Sep 03

Sino Biopharmaceutical Stock Rises 6.3% in Hong Kong, Outperforms Competitors

Dow Jones
·
Sep 03

Amgen to Present at Wells Fargo Healthcare Conference Webcast

Reuters
·
Sep 03

Political and General News Events from September 2

Reuters
·
Sep 02

Investors Shrug Off Good News for Heart Patients from New Meds

Dow Jones
·
Sep 02

Vertex Names Jonathan Poole CFO Effective Jan. 1, 2027

Reuters
·
Sep 01

Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements

Reuters
·
Sep 01

UK Regulator Suspends Avacopan Vifor for New Patients

MT Newswires Live
·
Sep 01

UK's Mhra : Informed Marketing Authorisation Holder of Decision to Suspend Use, Supply, Sale of Avacopan Vifor for New Patients from 1 September

THOMSON REUTERS
·
Sep 01

Why Is Amgen (AMGN) In Focus After New Repatha Survival Data?

Simply Wall St.
·
Sep 01

Trump Administration Announces Drug Pricing Deals with CSL, Astellas and Others

Reuters
·
Sep 01

Political and General News Events from August 31

Reuters
·
Aug 31

Amgen Says Repatha Cuts Death Risk 20% in High-Risk Patients

MT Newswires Live
·
Aug 31

Amgen Repatha reduces risk of death in high-risk adults for first heart attack

TIPRANKS
·
Aug 31

Amgen's Repatha® Reduces Risk of Death in Patients at High Risk for a First Heart Attack or Stroke

THOMSON REUTERS
·
Aug 31

Amgen Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Aug 29

Amgen’s Pediatric Psoriasis Study Wrap-Up: What Apremilast Safety Data Means for Investors

TIPRANKS
·
Aug 29

Political and General News Events from August 28

Reuters
·
Aug 28

Amgen’s AMG 691 Phase 1 Trial Targets Key Growth in Asian Markets

TIPRANKS
·
Aug 28